0
Lung Cancer |

Endobronchial Follicular Dendritic Cell Sarcoma FREE TO VIEW

Jennifer Butler, MD; Lenar Yessayan, MD; Mike Simoff, MD
Author and Funding Information

Henry Ford Hospital Detroit, Detroit, MI


Chest. 2015;148(4_MeetingAbstracts):539A. doi:10.1378/chest.2221244
Text Size: A A A
Published online

Abstract

SESSION TITLE: Lung Cancer Cases

SESSION TYPE: Affiliate Case Report Slide

PRESENTED ON: Sunday, October 25, 2015 at 10:45 AM - 12:00 PM

INTRODUCTION: Follicular dendritic cells are found in the germinal centers of lymph nodes or extranodal lymphoid tissue and present antigen to B -cells . Tumors are rare and they make up less than 1% of soft tissue sarcomas. Here we discuss the case of a follicular dendritic cell sarcoma occurring as an endobronchial tumor.

CASE PRESENTATION: A 19 year old African American female presented with fever, dyspnea, sore throat and productive cough. CT chest showed a 1cm endobronchial lesion within the right main bronchus causing lung collapse and post-obstructive pneumonia. She became hypoxic in the ER, intubated and started on broad spectrum antibiotic therapy. Fiberoptic bronchoscopy showed a 100% obstructing pearly-colored endobronchial lesion in the right mainstem bronchus just distal to the carina. She subsequently underwent rigid bronchoscopy with laser ablation and mechanical debulking. Frozen section revealed spindle cell sarcoma with necrosis, later identified as follicular dendritic cell sarcoma. Markers for CD35, vimentin, and CD99 were strongly positive. CT abdomen and pelvis was negative for metastatic disease. PET scan showed hypermetabolism in the right hilum and mild hypermetabolism in the axillary lymph nodes. She underwent right upper lobe sleeve lobectomy and level 10 lymph node resection, both specimens were negative for malignancy. Adjuvant chemotherapy was not given. Surveillance bronchoscopy with endobronchial biopsies years 1 and 2 post surgery were negative for recurrence.

DISCUSSION: FDC sarcoma is a rare tumor and often misdiagnosed as lymphoma or carcinoma. Staining for markers such as CD21, CD35 is helpful. The etiology remains controversial but suggested predisposing factors from the literature include hyaline-vascular Castleman disease, Epstein Barr virus, paraneoplastic pemphigus, and myasthenia gravis. Histologic features such as high mitotic count and coagulative necrosis are associated with unfavorable outcome. For localized disease, surgical resection is the therapy of choice. Adjuvant chemoradiation therapy is usually reserved for metastatic disease.

CONCLUSIONS: FDCS should be considered in the differential diagnosis of any spindled-cell tumor occurring in the lung.

Reference #1: Shia, Jinru, et al. Extranodal follicular dendritic cell sarcoma:clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity.Virchows Archiv 449.2 (2006):148-158.

Reference #2: Dalia, Samir, et al. Dendritic Cell and Histiocytic Neoplasms: Biology, Diagnosis, and Treatment.Cancer Control 21.4 (2014).

DISCLOSURE: The following authors have nothing to disclose: Jennifer Butler, Lenar Yessayan, Mike Simoff

No Product/Research Disclosure Information


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543